Yarbrough Capital »

Adaptive Biotechnologies Cor shares owned by Yarbrough Capital

Quarter-by-quarter ownership of Adaptive Biotechnologies Cor (ADPT) shares owned by Yarbrough Capital from 13F filings

Historical chart of Yarbrough Capital investment in Adaptive Biotechnologies Cor

Tip: Access up to 7 years of quarterly data

All positions including Adaptive Biotechnologies Cor held by Yarbrough Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptive Biotechnologies Cor by Yarbrough Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $427k 29k 14.96

More positions owned by Yarbrough Capital

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Vanguard World Inf Tech Etf (VGT)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Alphabet Cap Stk Cl C (GOOG)
Robinhood Mkts Com Cl A (HOOD)
Garmin SHS (GRMN)

View all positions for Yarbrough Capital

Top funds holding Adaptive Biotechnologies Cor

Viking Global Investors
BlackRock
Vanguard Group
Ameriprise Financial
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Geode Capital Management
ARK Investment Management
Aristotle Atlantic Partners
State Street Corporation
Driehaus Capital Management
Fred Alger Management
Arrowstreet Capital, Limited Partnership
Blue Water Life Science Advisors
Macquarie Group

View all funds holding Adaptive Biotechnologies Cor